Researchers Submit Patent Application, "Immunogenic Compositions", for Approval (USPTO 20240181026).
In: Zika & Mosquito Week, 2024-06-28, S. 2814-2814
serialPeriodical
Zugriff:
A patent application has been submitted for immunogenic compositions that could potentially prevent malaria. The application focuses on the development of a highly effective vaccine for malaria control and elimination. The invention involves administering peptide antigens to induce antibodies against Plasmodium falciparum sporozoites, which cause malaria infection. The goal is to generate more potent protective immune responses and improve vaccine efficacy. The patent application provides specific details on the method and amino acid sequences used in treating or preventing malaria. [Extracted from the article]
Copyright of Zika & Mosquito Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Researchers Submit Patent Application, "Immunogenic Compositions", for Approval (USPTO 20240181026).
|
---|---|
Zeitschrift: | Zika & Mosquito Week, 2024-06-28, S. 2814-2814 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
Schlagwort: |
|
Sonstiges: |
|